SPRO logo

Spero Therapeutics, Inc. (SPRO)

Profile

Full Name

Spero Therapeutics, Inc.

Ticker

NASDAQ: SPRO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 2, 2017

Indexes

Not included

Website

https://sperotherapeutics.com

Employees

32

Key Details

Price

$2.33(-0.85%)

Market Cap

$131.27M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$27.40M(-71.68% YoY)

Annual EPS

-$1.27(-394.80% YoY)

PE Ratio

-

Next earnings date

Mar 26, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.33
    SPRO price is $2.33

    30-Day Relative Volume

    0.55
    SPRO 30-day relative volume is 0.55

    Price Performance

    Price 1-Day Change

    -0.85%
    SPRO price is down -0.85% today

    Price YTD Change

    +126.21%
    SPRO price is up +126.21% since January 1st

    Price 1-Year Change

    +111.82%
    SPRO price is up +111.82% year-on-year

    Price 3-Year Change

    +37.06%
    SPRO price is up +37.06% over the past 3 years

    Price Range

    Price All-Time High

    $23.64
    SPRO price is currently -90.14% below its historical high of $23.64

    Price 3-Year Low

    $0.51
    SPRO price is currently +361.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $131.27M
    SPRO market cap is $131.27 million

    Market Cap 3-Year Change

    +49.14%
    SPRO market cap is up +49.14% over the past 3 years

    Market Cap All-Time High

    $628.51M
    SPRO market cap is currently -79.11% below its historical high of $628.51 million

    Market Cap Sector Percentile

    43.58%
    SPRO market cap is higher than 43.58% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.34%
    SPRO shares outstanding is up +3.34% year-on-year

    Shares Outstanding 3-Year Change

    +8.81%
    SPRO shares outstanding is up +8.81% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.45
    SPRO beta is 0.45

    200-day SMA

    $1.83
    SPRO price is currently +27.15% above its 200-day simple moving average

    50-day SMA

    $2.33
    SPRO price is currently -0.07% below its 50-day simple moving average

    14-Day RSI

    51.46
    SPRO 14-day relative strength index is 51.46

    Volume

    0.55
    SPRO 30-day relative volume is 0.55

    ATR

    $0.11
    SPRO average true range is $0.11

    10-day Historical Volatility

    43.67%
    SPRO 10-day historical volatility is 43.67%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $27.40M
    SPRO annual revenue is $27.40 million

    Revenue Analysts Estimate

    -
    SPRO annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -71.68%
    SPRO annual revenue is down -71.68% year-on-year

    Revenue Sector Percentile

    55.55%
    SPRO annual revenue is higher than 55.55% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    SPRO annual earnings per share is -$1.27

    EPS Analysts Estimate

    -$0.13
    SPRO annual earnings per share is currently -876.00% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -394.8%
    SPRO annual earnings per share is down -394.8% year-on-year

    EPS Sector Percentile

    50.25%
    SPRO annual earnings per share is higher than 50.25% of companies in Healthcare sector

    Profit

    Gross Profit

    $27.39M
    SPRO annual gross profit is $27.39 million

    Gross Margin

    99.99%
    SPRO annual gross profit margin is 99.99%

    Operating Profit

    -$72.48M
    SPRO annual operating income is -$72.48 million

    Operating Margin

    -339.70%
    SPRO annual operating profit margin is -339.70%

    Net Income

    -$68.57M
    SPRO annual net profit is -$68.57 million

    Net Margin

    -250.28%
    SPRO annual net profit margin is -250.28%

    Expenses

    Total Expenses

    $99.88M
    SPRO annual total expenses is $99.88 million

    Operating Expenses

    $99.88M
    SPRO annual total operating expenses is $99.88 million

    Cost Of Goods Sold

    $2000.00
    SPRO annual cost of goods sold is $2000.00

    Selling, General & Administrative Expenses

    $23.70M
    SPRO annual SG&A is $23.70 million

    Depreciation & Amortization

    $2000.00
    SPRO annual D&A is $2000.00

    Interest Expense

    $0.00
    SPRO annual interest expense is $0.00

    Income Tax

    $0.00
    SPRO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$72.48M
    SPRO annual earnings before interest & taxes is -$72.48 million

    EBITDA

    -$72.48M
    SPRO annual EBITDA is -$72.48 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $110.54M
    SPRO annual total assets is $110.54 million

    Non Current Assets

    $3.27M
    SPRO annual long term assets is $3.27 million

    Current Assets

    $107.28M
    SPRO annual total current assets is $107.28 million

    Cash and Cash Equivalents

    $52.89M
    SPRO annual cash & cash equivalents is $52.89 million

    Accounts Receivable

    $49.39M
    SPRO annual accounts receivable is $49.39 million

    Inventory

    $0.00
    SPRO annual inventory is $0.00

    Liabilities

    Total Liabilities

    $64.42M
    SPRO annual total liabilities is $64.42 million

    Long Term Liabilities

    $15.35M
    SPRO annual total long term liabilities is $15.35 million

    Current Liabilities

    $49.07M
    SPRO annual current liabilities is $49.07 million

    Accounts Payable

    $7.31M
    SPRO annual accounts payable is $7.31 million

    Debt

    Total Debt

    $4.30M
    SPRO annual total debt is $4.30 million

    Total Debt 1-Year Change

    -22.48%
    SPRO annual total debt is down -22.48% year-on-year

    Long Term Debt

    $2.55M
    SPRO annual long term debt is $2.55 million

    Short Term Debt

    $1.75M
    SPRO annual short term debt is $1.75 million

    Equity & Capital

    Shareholders Equity

    $46.12M
    SPRO annual stockholders equity is $46.12 million

    Book Value

    $46.12M
    SPRO annual book value is $46.12 million

    Retained Earnings

    -$459.64M
    SPRO annual retained earnings is -$459.64 million

    Working Capital

    $58.20M
    SPRO annual working capital is $58.20 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$23.44M
    SPRO annual cash from operations is -$23.44 million

    Cash From Operations 1-Year Change

    +28.95%
    SPRO annual cash from operations is up +28.95% year-on-year

    Cash From Investing

    $0.00
    SPRO annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    0%
    SPRO annual cash from investing has remained unchanged year-on-year

    Cash From Financing

    $0.00
    SPRO annual cash from financing is $0.00

    Cash From Financing 1-Year Change

    -100%
    SPRO annual cash from financing is down -100% year-on-year

    CAPEX

    CAPEX

    $0.00
    SPRO annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    SPRO annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$23.44M
    SPRO annual free cash flow is -$23.44 million

    Free Cash Flow 1-Year Change

    +28.95%
    SPRO annual free cash flow is up +28.95% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    99.99%
    SPRO annual gross profit margin is 99.99%

    Operating Margin

    -339.70%
    SPRO annual operating profit margin is -339.70%

    Net Margin

    -250.28%
    SPRO annual net profit margin is -250.28%

    ROA & ROE

    ROA

    -46.81%
    SPRO annual return on assets is -46.81%

    ROE

    -89.62%
    SPRO annual return on equity is -89.62%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    SPRO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    SPRO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    4.95
    SPRO price to book ratio is 4.95

    PB Ratio Sector Percentile

    75.67%
    SPRO price to book ratio is higher than 75.67% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    4.48
    SPRO price to sales ratio is 4.48

    PS Ratio Sector Percentile

    53.15%
    SPRO price to sales ratio is higher than 53.15% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $86.01M
    SPRO enterprise value is $86.01 million

    Enterprise Value Sector Percentile

    42.18%
    SPRO enterprise value is higher than 42.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.53
    SPRO EV/EBITDA is -1.53

    EV/EBITDA Sector Percentile

    42.17%
    SPRO EV/EBITDA is higher than 42.17% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.19
    SPRO annual current ratio is 2.19

    Quick Ratio

    2.19
    SPRO annual quick ratio is 2.19

    Leverage

    Debt To Equity

    0.09
    SPRO annual debt to equity ratio is 0.09

    Interest Coverage Ratio

    -
    SPRO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    SPRO piotroski f-score is 3

    Altman Z-Score

    -5.88
    SPRO altman z-score is -5.88

    Analyst ratings

    Recent major analysts updates

    Jan 30, 25 HC Wainwright & Co.
    Buy
    Dec 20, 24 Evercore ISI Group
    In-Line
    Dec 2, 24 HC Wainwright & Co.
    Buy
    Nov 18, 24 TD Cowen
    Hold
    Nov 15, 24 Cantor Fitzgerald
    Overweight
    Nov 4, 24 HC Wainwright & Co.
    Buy
    Oct 3, 24 HC Wainwright & Co.
    Buy
    Aug 6, 24 TD Cowen
    Buy
    Aug 6, 24 HC Wainwright & Co.
    Buy
    Aug 6, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with SPRO included

    Growing Shares Outstanding
    US stocks
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for Spero Therapeutics, Inc.?
    • Does Spero Therapeutics, Inc. pay dividends?
    • What sector is Spero Therapeutics, Inc. in?
    • What industry is Spero Therapeutics, Inc. in?
    • What country is Spero Therapeutics, Inc. based in?
    • When did Spero Therapeutics, Inc. go public?
    • Is Spero Therapeutics, Inc. in the S&P 500?
    • Is Spero Therapeutics, Inc. in the NASDAQ 100?
    • Is Spero Therapeutics, Inc. in the Dow Jones?
    • When was Spero Therapeutics, Inc.'s last earnings report?
    • When does Spero Therapeutics, Inc. report earnings?

    What is the ticker symbol for Spero Therapeutics, Inc.?

    The ticker symbol for Spero Therapeutics, Inc. is NASDAQ:SPRO

    Does Spero Therapeutics, Inc. pay dividends?

    No, Spero Therapeutics, Inc. does not pay dividends

    What sector is Spero Therapeutics, Inc. in?

    Spero Therapeutics, Inc. is in the Healthcare sector

    What industry is Spero Therapeutics, Inc. in?

    Spero Therapeutics, Inc. is in the Biotechnology industry

    What country is Spero Therapeutics, Inc. based in?

    Spero Therapeutics, Inc. is headquartered in United States

    When did Spero Therapeutics, Inc. go public?

    Spero Therapeutics, Inc.'s initial public offering (IPO) was on November 2, 2017

    Is Spero Therapeutics, Inc. in the S&P 500?

    No, Spero Therapeutics, Inc. is not included in the S&P 500 index

    Is Spero Therapeutics, Inc. in the NASDAQ 100?

    No, Spero Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Spero Therapeutics, Inc. in the Dow Jones?

    No, Spero Therapeutics, Inc. is not included in the Dow Jones index

    When was Spero Therapeutics, Inc.'s last earnings report?

    Spero Therapeutics, Inc.'s most recent earnings report was on November 13, 2025

    When does Spero Therapeutics, Inc. report earnings?

    The next expected earnings date for Spero Therapeutics, Inc. is March 26, 2026
    On this page